Symbol
| BDKRB1
| contributors: mct - updated : 16-04-2020
|
HGNC name
| bradykinin receptor B1
|
HGNC id
| 1029
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in subcutaneous white adipose tissue (sWAT) in patients with coronary artery disease (CAD) | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| serum BDKRB1 levels may provide prognostic information and currently act as potential indicators for progression in atherosclerosis | Therapy target
|
System | Type | Disorder | Pubmed |
immunology | inflammatory | | |
its inhibition can reduce BBB damage and cell invasion during autoimmune CNS disease and may offer a novel anti-inflammatory strategy for the treatment of MS | miscelleaneous | urinary | | |
blockade of the BDKRB1 has significant potential for the treatment of glomerulonephritis |
| | |
| Bdkrb1 is upregulated by the oxidative stress in the brain of insulin-resistant rats and its activation causes stereotypic nocifensive behavior through the release of substance P, glutamate and NO |